Display options
Cite
Diehl CJ, Barish GD, Downes M, et al. Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells. Mol Endocrinol. 2011;25(3):529-45doi: 10.1210/me.2010-0384.
Diehl, C. J., Barish, G. D., Downes, M., Chou, M. Y., Heinz, S., Glass, C. K., Evans, R. M., & Witztum, J. L. (2011). Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells. Molecular endocrinology (Baltimore, Md.), 25(3), 529-45. https://doi.org/10.1210/me.2010-0384
Diehl, Cody J, et al. "Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells." Molecular endocrinology (Baltimore, Md.) vol. 25,3 (2011): 529-45. doi: https://doi.org/10.1210/me.2010-0384
Diehl CJ, Barish GD, Downes M, Chou MY, Heinz S, Glass CK, Evans RM, Witztum JL. Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells. Mol Endocrinol. 2011 Mar;25(3):529-45. doi: 10.1210/me.2010-0384. Epub 2011 Jan 27. PMID: 21273443; PMCID: PMC3045740.
Copy Download .nbib Format: NLM
Share it on

Mol Endocrinol. 2011 Mar;25(3):529-45. doi: 10.1210/me.2010-0384. Epub 2011 Jan 27.

Research resource: Comparative nuclear receptor atlas: basal and activated peritoneal B-1 and B-2 cells.

Molecular endocrinology (Baltimore, Md.)

Cody J Diehl, Grant D Barish, Michael Downes, Meng-Yun Chou, Sven Heinz, Christopher K Glass, Ronald M Evans, Joseph L Witztum

Affiliations

  1. Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, USA.

PMID: 21273443 PMCID: PMC3045740 DOI: 10.1210/me.2010-0384

Abstract

Naïve murine B cells are typically divided into three subsets based on functional and phenotypic characteristics: innate-like B-1 and marginal zone B cells vs. adaptive B-2 cells, also known as follicular or conventional B cells. B-1 cells, the innate-immune-like component of the B cell lineage are the primary source of natural antibodies and have been shown to modulate autoimmune diseases, human B-cell leukemias, and inflammatory disorders such as atherosclerosis. On the other hand, B-2 cells are the principal mediators of the adaptive humoral immune response and represent an important pharmacological target for various conditions including rheumatoid arthritis, lupus erythematosus, and lymphomas. Using the resources of the Nuclear Receptor Signaling Atlas program, we used quantitative real-time PCR to assess the complement of the 49 murine nuclear receptor superfamily expressed in quiescent and toll-like receptor (TLR)-stimulated peritoneal B-1 and B-2 cells. We report the expression of 24 nuclear receptors in basal B-1 cells and 25 nuclear receptors in basal B-2 cells, with, in some cases, dramatic changes in response to TLR 4 or TLR 2/1 stimulation. Comparative nuclear receptor profiling between B-1 and peritoneal B-2 cells reveals a highly concordant expression pattern, albeit at quantitatively dissimilar levels. We also found that splenic B cells express 23 nuclear receptors. This catalog of nuclear receptor expression in B-1 and B-2 cells provides data to be used to better understand the specific roles of nuclear receptors in B cell function, chronic inflammation, and autoimmune disease.

References

  1. Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S73-81 - PubMed
  2. Endocr Rev. 2000 Jun;21(3):292-312 - PubMed
  3. Cell. 2004 Feb 20;116(4):527-40 - PubMed
  4. J Clin Invest. 2010 Sep;120(9):3350-64 - PubMed
  5. Immunol Rev. 2000 Jun;175:70-9 - PubMed
  6. J Exp Med. 1988 Jul 1;168(1):55-71 - PubMed
  7. J Leukoc Biol. 1993 Jul;54(1):17-22 - PubMed
  8. J Exp Med. 1999 Jun 7;189(11):1685-90 - PubMed
  9. Cell. 2008 Jul 11;134(1):97-111 - PubMed
  10. J Biol Chem. 2002 Mar 1;277(9):6838-45 - PubMed
  11. Immunity. 1995 Sep;3(3):273-82 - PubMed
  12. Cell. 1999 Apr 16;97(2):161-3 - PubMed
  13. Mol Endocrinol. 2005 Sep;19(9):2211-21 - PubMed
  14. Semin Immunol. 2009 Feb;21(1):36-41 - PubMed
  15. Genes Dev. 2001 Dec 15;15(24):3263-77 - PubMed
  16. Cell Immunol. 1997 Dec 15;182(2):99-104 - PubMed
  17. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):282-8 - PubMed
  18. Science. 1988 Oct 28;242(4878):583-5 - PubMed
  19. Gene. 1998 Aug 31;216(2):277-83 - PubMed
  20. J Immunol. 2007 Jun 15;178(12):7779-86 - PubMed
  21. Crit Rev Immunol. 2010;30(1):1-29 - PubMed
  22. Cell Immunol. 2007 Sep;249(1):37-45 - PubMed
  23. Clin Cancer Res. 2008 May 15;14(10):3011-21 - PubMed
  24. Cold Spring Harb Symp Quant Biol. 1999;64:363-71 - PubMed
  25. Endocrinology. 1995 Nov;136(11):4887-93 - PubMed
  26. Mol Immunol. 2007 Feb;44(6):1436-45 - PubMed
  27. Science. 1987 Jul 17;237(4812):268-75 - PubMed
  28. J Immunol. 2000 Jan 1;164(1):152-60 - PubMed
  29. J Biol Chem. 2000 Nov 24;275(47):36703-7 - PubMed
  30. J Biol Chem. 2001 Oct 12;276(41):37735-8 - PubMed
  31. Am J Physiol Regul Integr Comp Physiol. 2007 Jun;292(6):R2357-67 - PubMed
  32. Immunol Rev. 2008 Aug;224:201-14 - PubMed
  33. J Exp Med. 2006 Oct 2;203(10):2305-14 - PubMed
  34. J Clin Invest. 2009 May;119(5):1335-49 - PubMed
  35. J Immunol. 2002 Dec 15;169(12):6806-12 - PubMed
  36. Prog Clin Biol Res. 1990;332:81-97 - PubMed
  37. Genes Dev. 2007 Aug 1;21(15):1909-20 - PubMed
  38. Annu Rev Nutr. 2001;21:167-92 - PubMed
  39. Springer Semin Immunopathol. 2005 Mar;26(4):347-62 - PubMed
  40. J Immunol. 2010 Jan 1;184(1):191-202 - PubMed
  41. J Gen Virol. 2003 Feb;84(Pt 2):319-327 - PubMed
  42. Science. 2001 Nov 30;294(5548):1866-70 - PubMed
  43. J Invest Dermatol. 2008 Aug;128(8):1940-9 - PubMed
  44. Diabetes. 1997 Aug;46(8):1319-27 - PubMed
  45. J Immunol. 2002 Mar 15;168(6):2795-802 - PubMed
  46. J Clin Immunol. 2003 Jan;23(1):46-54 - PubMed
  47. J Lipid Res. 2009 Apr;50 Suppl:S388-93 - PubMed
  48. J Immunol. 1993 Jan 15;150(2):407-18 - PubMed
  49. Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17534-9 - PubMed
  50. J Biol Chem. 2004 Apr 23;279(17):17543-53 - PubMed
  51. J Exp Med. 1994 Jul 1;180(1):111-21 - PubMed
  52. Physiol Rev. 2001 Jul;81(3):1097-142 - PubMed
  53. Ann N Y Acad Sci. 1995 Sep 29;764:402-9 - PubMed
  54. J Immunol. 2005 May 15;174(10):6308-13 - PubMed
  55. Mol Endocrinol. 2008 Jul;22(7):1509-20 - PubMed
  56. J Clin Invest. 2002 Jun;109(12):1625-33 - PubMed
  57. Mol Endocrinol. 2005 Oct;19(10):2466-77 - PubMed
  58. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15131-6 - PubMed
  59. Int Immunol. 2001 Apr;13(4):553-8 - PubMed
  60. Blood. 1995 Mar 15;85(6):1535-9 - PubMed
  61. J Exp Med. 1983 Jan 1;157(1):202-18 - PubMed
  62. Eur J Immunol. 2007 Nov;37(11):3040-53 - PubMed
  63. Endocrinology. 1992 Nov;131(5):2419-29 - PubMed
  64. FEBS Lett. 2004 Mar 12;561(1-3):69-74 - PubMed
  65. Science. 2003 Oct 17;302(5644):453-7 - PubMed
  66. J Lipid Res. 2002 Nov;43(11):1773-808 - PubMed
  67. Trends Endocrinol Metab. 2008 Oct;19(8):269-76 - PubMed
  68. Mol Endocrinol. 1994 Aug;8(8):996-1005 - PubMed
  69. Nucleic Acids Res. 1997 Nov 1;25(21):4296-300 - PubMed
  70. J Lipid Res. 2006 May;47(5):1097-111 - PubMed
  71. Hypertension. 2003 Jul;42(1):49-55 - PubMed
  72. Science. 1983 Sep 16;221(4616):1181-3 - PubMed
  73. Hypertension. 2009 Sep;54(3):537-43 - PubMed
  74. Nat Rev Immunol. 2004 Jul;4(7):499-511 - PubMed
  75. Semin Immunol. 1996 Feb;8(1):45-59 - PubMed
  76. J Rheumatol. 1998 Jul;25(7):1305-12 - PubMed
  77. Eur J Immunol. 2006 May;36(5):1114-23 - PubMed
  78. Eur J Neurosci. 1997 Dec;9(12):2687-701 - PubMed
  79. J Immunol. 1993 Jun 1;150(11):4822-32 - PubMed
  80. J Immunol. 1999 Jun 15;162(12):7198-207 - PubMed
  81. EMBO J. 2008 Sep 17;27(18):2353-62 - PubMed
  82. Science. 1999 Jul 30;285(5428):736-9 - PubMed
  83. Mt Sinai J Med. 1998 Mar;65(2):104-7 - PubMed
  84. Pharmacol Ther. 2009 Nov;124(2):141-50 - PubMed
  85. J Clin Invest. 1990 Jan;85(1):101-5 - PubMed
  86. J Clin Invest. 2006 Mar;116(3):590-7 - PubMed
  87. Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277-300 - PubMed
  88. Mol Endocrinol. 2008 Aug;22(8):1797-811 - PubMed
  89. Clin Immunol. 2005 Jan;114(1):17-26 - PubMed
  90. J Clin Invest. 2000 Jun;105(12):1731-40 - PubMed
  91. J Exp Med. 1993 Nov 1;178(5):1507-15 - PubMed
  92. Nucl Recept Signal. 2009;7:e003 - PubMed
  93. Nature. 1994 Jan 20;367(6460):281-4 - PubMed
  94. Curr Opin Investig Drugs. 2005 May;6(5):467-72 - PubMed

Substances

MeSH terms

Publication Types

Grant support